A Florida woman filed a lawsuit Thursday night against artificial tear maker EzriCare and Walmart after suffering a bacterial infection which she said was caused by the eye drops.

Houston-based Lange Law Firm, which represents the woman, Teresa Phillips, 60, of Bradford County, said the lawsuit is the first nationwide for eye drop-related injuries related to an infection. drug-resistant bacteria called Pseudomonas aeruginosa.

The lawsuit was filed in the US District Court for the Middle District of Florida.

According to the lawsuit, Phillips purchased EzriCare artificial tears in the weeks before her infection.

In May, Phillips said he felt «itchy» and had «non-stop pain in his eyes.» She underwent a round of antibiotics, according to the lawsuit, but after a week «it became apparent that the antibiotics were not working to stop the infection.»

Phillips had to undergo surgery to remedy some of the issues related to the infection and is still experiencing symptoms, according to the firm.

EzriCare artificial tears have been linked to at least 56 cases of bacterial infection in 12 states. Five of those people so far have had vision loss. One person died when the bacteria entered the bloodstream. Doctors say there could be more cases.

The manufacturer of the eye drops, Global Pharma Healthcare, announced on February 2 that it would voluntarily recall the product due to possible contamination.

While the eye drops have not yet been definitively traced to infections, the Centers for Disease Control and Prevention and the Food and Drug Administration say they are currently working with state and local health officials to investigate the outbreak. In an alert announced last week, the CDC said he had collected specimens from May 2022 to January.

Global Pharma and Walmart did not immediately respond to requests for comment on the lawsuit.

The FDA first learned of the Pseudomonas aeruginosa outbreak in December and discovered link to EzriCare drops in January, according to an FDA spokesperson Audra Harrison.

EzriCare drops are not FDA-approved products, the agency said, and are legally marketed under a regulatory pathway that allows the sale of over-the-counter products that meet certain requirements. The FDA does not pre-review or approve these types of products, the agency said.

Continue NBC HEALTH in Twitter & Facebook.

Erika Edwards contributed.